Literature DB >> 10822326

JC virus binds to primary human glial cells, tonsillar stromal cells, and B-lymphocytes, but not to T lymphocytes.

G Wei1, C K Liu, W J Atwood.   

Abstract

The human polyomavirus, JCV, is the etiological agent of the fatal central nervous system demyelinating disease, progressive multifocal leukoencephalopathy (PML). In PML patients, JC Virus (JCV) can be detected in glial cells in the central nervous system (CNS); in B-lymphocytes in the peripheral blood, bone marrow, spleen, and tonsil; and in tonsillar stromal cells. In vitro, JCV infects glial cells, tonsillar stromal cells, and to a limited extent B-lymphocytes. The presence or absence of as yet unidentified cell type specific transcription factors contributes to the restricted tropism of JCV for these cell types. However, several studies indicate that cell surface receptors may also contribute to the limited host range of JCV. To examine this latter possibility we measured the binding of purified JCV virions to primary cultures of glial cells, tonsillar stromal cells, peripheral blood lymphocytes, and to several established cell lines. Our results demonstrate that JCV binds to primary glial cells, stromal cells, and B cells, but does not bind to primary T cells. In contrast, JCV bound to all cell lines tested, including the Namalwa B cell line and the Jurkat T cell line. These data are novel and demonstrate that JCV selectively interacts with cells in vivo that are known to be susceptible to infection. This selectivity appears to be lost when one examines virus binding to a variety of human, monkey, or mouse tumor cell lines. We next examined the susceptibility of primary peripheral blood lymphocytes and the Namalwa B cell line to infection with JCV. Our results demonstrate that the majority of infectious JCV virions remain cell surface associated and do not efficiently establish infection of B cells. This may explain the in vivo observation that JCV DNA is frequently detected in association with lymphocytes by PCR but that JCV mRNA is rarely detected in association with lymphocytes by reverse transcriptase PCR. These results also confirm previous data regarding the association of JCV with human B cells in vivo and support the hypothesis that B cells may be involved in trafficking of JCV to the CNS.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10822326     DOI: 10.3109/13550280009013156

Source DB:  PubMed          Journal:  J Neurovirol        ISSN: 1355-0284            Impact factor:   2.643


  29 in total

Review 1.  Virus receptors in the human central nervous system.

Authors:  B Schweighardt; W J Atwood
Journal:  J Neurovirol       Date:  2001-06       Impact factor: 2.643

2.  JC virus regulatory region tandem repeats in plasma and central nervous system isolates correlate with poor clinical outcome in patients with progressive multifocal leukoencephalopathy.

Authors:  L A Pfister; N L Letvin; I J Koralnik
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

3.  Microarray analysis of glial cells resistant to JCV infection suggests a correlation between viral infection and inflammatory cytokine gene expression.

Authors:  Kate Manley; Gretchen V Gee; Carl P Simkevich; John M Sedivy; Walter J Atwood
Journal:  Virology       Date:  2007-06-06       Impact factor: 3.616

4.  JC virus multiplication in human hematopoietic progenitor cells requires the NF-1 class D transcription factor.

Authors:  M C Monaco; B F Sabath; L C Durham; E O Major
Journal:  J Virol       Date:  2001-10       Impact factor: 5.103

5.  Diffuse large B cell lymphoma secondary to JC virus in progressive multifocal leukoencephalopathy.

Authors:  Ashwin Reddi; Nikhil Patel; Nicholas A Morris
Journal:  J Neurovirol       Date:  2019-05-28       Impact factor: 2.643

6.  JC polyomavirus expression and bell-shaped regulation of its SF2/ASF suppressor during the follow-up of multiple sclerosis patients treated with natalizumab.

Authors:  Elena Uleri; Gabriele Ibba; Claudia Piu; Maurizio Caocci; Stefania Leoni; Giannina Arru; Caterina Serra; GianPietro Sechi; Antonina Dolei
Journal:  J Neurovirol       Date:  2016-11-03       Impact factor: 2.643

7.  Identical rearranged forms of JC polyomavirus transcriptional control region in plasma and cerebrospinal fluid of acquired immunodeficiency syndrome patients with progressive multifocal leukoencephalopathy.

Authors:  Cesare Giovanni Fedele; Maria Rosa Ciardi; Salvatore Delia; Gerardo Contreras; José Luis Perez; Maria De Oña; Elisa Vidal; Antonio Tenorio
Journal:  J Neurovirol       Date:  2003-10       Impact factor: 2.643

Review 8.  Immune surveillance and response to JC virus infection and PML.

Authors:  Sarah Beltrami; Jennifer Gordon
Journal:  J Neurovirol       Date:  2013-12-03       Impact factor: 2.643

9.  The human alpha defensin HD5 neutralizes JC polyomavirus infection by reducing endoplasmic reticulum traffic and stabilizing the viral capsid.

Authors:  Stephen R Zins; Christian D S Nelson; Melissa S Maginnis; Rahul Banerjee; Bethany A O'Hara; Walter J Atwood
Journal:  J Virol       Date:  2013-11-06       Impact factor: 5.103

10.  Cell penetration and trafficking of polyomavirus.

Authors:  Joanna M Gilbert; Ilya G Goldberg; Thomas L Benjamin
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.